The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis
Open accessAbstract
Bisphosphonates (BPs) include potent inhibitors of bone resorption used to treat osteoporosis and other bone diseases. BPs directly or indirectly induce apoptosis in osteoclasts, the bone resorbing cells, and this may play a role in inhibition of bone resorption. Little is known about downstream mediators of apoptosis in osteoclasts, which are difficult to culture. Using purified osteoclasts, we examined the effects of alendronate, risedronate, pamidronate, etidronate, and clodronate on apoptosis and signaling kinases. All BPs induce caspase-dependent formation of pyknotic nuclei and cleavage of Mammalian Sterile 20-like (Mst) kinase 1 to form the active 34-kDa species associated with apoptosis. Withdrawal of serum and of macrophage colony stimulating factor, necessary for survival of purified osteoclasts, or treatment with staurosporine also induce apoptosis and caspase cleavage of Mst1. Consistent with their inhibition of the mevalonate pathway, apoptosis and cleavage of Mst1 kinase induced by alendronate, risedronate, and lovastatin, but not clodronate, are blocked by geranylgeraniol, a precursor of geranylgeranyl diphosphate. Together these findings suggest that BPs act directly on the osteoclast to induce apoptosis and that caspase cleavage of Mst1 kinase is part of the apoptotic pathway. For alendronate and risedronate, these events seem to be downstream of inhibition of geranylgeranylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,040
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Self-citationFisher, J. E., Rogers, M. J., Halasy, J. M., Luckman, S. P., Hughes, D. E., Masarachia, P. J., Wesolowski, G., Russell, R. G. G., Rodan, G. A., & Reszka, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.133 · Cited by 676
Self-citationKameshita, I., & Fujisawa, H. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90181-4 · Cited by 458
Frith, J. C., Mönkkönen, J., Blackburn, G. M., Russell, R. G. G., & Rogers, M. J. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.9.1358 · Cited by 437
Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1
Graves, J. D. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2224 · Cited by 376
GOTOH, Y., NISHIDA, E., YAMASHITA, T., HOSHI, M., KAWAKAMI, M., & SAKAI, H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19384.x · Cited by 376
MECHANISMS OF ACTION OF BISPHOSPHONATES
Rodan, G. A. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.375 · Cited by 304
Self-citationLuckman, S. P., Coxon, F. P., Ebetino, F. H., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.11.1668 · Cited by 272
Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.
Selander, K. S., Mönkkönen, J., Karhukorpi, E. K., Härkönen, P., Hannuniemi, R., & Väänänen, H. K. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09541-0 · Cited by 237
Mortensen, L., Charles, P., Bekker, P. J., Digennaro, J., & Johnston, C. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4586 · Cited by 220
The Ste20-like Protein Kinase, Mst1, Dimerizes and Contains an Inhibitory Domain
Creasy, C. L., Ambrose, D. M., & Chernoff, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21049 · Cited by 204
van Beek, E., Pieterman, E., Cohen, L., Löwik, C., & Papapoulos, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0224 · Cited by 195
Schmidt, A., Rutledge, S. J., Endo, N., Opas, E. E., Tanaka, H., Wesolowski, G., Leu, C. T., Huang, Z., Ramachandaran, C., Rodan, S. B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.3068 · Cited by 194
Self-citationEsophageal Irritation due to Alendronate Sodium Tablets (Possible Mechanisms)
Peter, C. P., Handt, L. K., & Smith, S. M. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018894827961 · Cited by 132
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase
David, P., Nguyen, H., Barbier, A., & Baron, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111017 · Cited by 102
Molecular mechanisms of bone resorption
Teitelbaum, S. L., Abu‐Amer, Y., & Ross, F. P. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590102 · Cited by 94
Lee, K.-K., Murakawa, M., Takahashi, S., Tsubuki, S., Kawashima, S., Sakamaki, K., & Yonehara, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19160 · Cited by 90
Coxon, F. P., Benford, H. L., Russell, R. G. G., et al. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13063-5 · Cited by 89
Isolation and Characterization of Highly Enriched, Prefusion Mouse Osteoclastic Cells
Wesolowski, G. A., Duong, L. T., Lakkakorpi, P. T., Nagy, R. M., Tezuka, K.-I., Tanaka, H., Rodan, G. A., & Rodan, S. B. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1279 · Cited by 85
Self-citationKakeya, H., Onose, R., & Osada, H. (1998) · PubMed · Cited by 78
Comparative Study of Potential for Bisphosphonates to Damage Gastric Mucosa of Rats
Peter, C. P., Kindt, M. V., & Majka, J. A. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018826600877 · Cited by 55
Inhibitors of prenyl transferases
Sebti, S. M., & Hamilton, A. D. (1997) · Current Opinion in Oncology · doi:10.1097/00001622-199711000-00011 · Cited by 52
Alendronate inhibition of protein-tyrosine-phosphatase-meg1
Opas, E. E., Rutledge, S. J., Golub, E. E., Stern, A. M., Zimoio, Z., Rodan, G. A., & Schmidt, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00225-6 · Cited by 36
Self-citation
Cited by
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Therapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Self-citationDunford, J. E., Thompson, K., Coxon, F. P., Luckman, S. P., Hahn, F. M., Poulter, C. D., Ebetino, F. H., & Rogers, M. J. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38786-5 · Cited by 900
Molecular Mechanisms of Action of Bisphosphonates: Current Status
Roelofs, A. J., Thompson, K., Gordon, S., & Rogers, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0843 · Cited by 568
Biochemical and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Crockett, J. C., Coxon, F. P., & Mönkkönen, J. (2011) · Bone · doi:10.1016/j.bone.2010.11.008 · Cited by 530
Metadata
- Authors
- Reszka, A. A., Halasy-Nagy, J. M., Masarachia, P. J., & Rodan, G. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 274
- Issue
- 49
- Pages
- 34967-34973
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1966064911
- Cited by
- 254
- References
- 27
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.